The short answer
Botulinum toxin (commercially BOTOX®, Dysport®, Xeomin®, and others) has been in clinical use since 1989 for medical indications and since 2002 for aesthetic indications. After more than 30 years and millions of treated patients, it has one of the strongest safety records in medicine.
Real risks exist, but they cluster around three categories: (1) cosmetic side-effects from imprecise injection, (2) very rare allergic reactions, and (3) extremely rare systemic spread. Each is manageable with proper protocol.
What botulinum toxin actually is
Botulinum toxin Type A is a purified protein produced by the bacterium Clostridium botulinum. In raw, undiluted form it is one of the most potent neurotoxins known — this is the source of the "BOTOX is poison" framing in popular media.
What's used in aesthetic medicine is a tiny dose of highly purified, dose-standardised protein, diluted in saline to a precise concentration. Typical aesthetic dosing is 20–60 units total per session. The estimated human toxic dose is approximately 3,000 units — meaning a typical session delivers less than 2% of the toxic threshold.
The protein binds to specific receptors at the neuromuscular junction (where nerves meet muscles) and temporarily prevents the release of acetylcholine, the neurotransmitter that signals muscle contraction. The target muscle relaxes for 3 to 4 months as new neuromuscular connections gradually re-form.
What the safety data actually shows
Clinical trials
The original FDA approval studies and subsequent post-market surveillance have tracked side effects across millions of patient sessions. The consistent findings:
- Common side effects (1–10%): mild bruising or swelling at injection sites, transient headache
- Less common (under 1%): temporary eyelid drooping (ptosis), eyebrow heaviness, asymmetry
- Rare (under 0.1%): allergic reactions, mild flu-like symptoms after first treatment
- Very rare (case reports only): systemic spread of toxin causing distant muscle weakness
The "very rare" category, explained
The FDA added a black-box warning in 2009 about possible spread of toxin from the injection site, particularly when used at high doses for medical indications (cerebral palsy, spasticity). For aesthetic dosing, the case reports are essentially absent — the doses are an order of magnitude lower.
How a safe protocol actually works
Most adverse outcomes from neurotoxin happen not because the product is unsafe, but because of injection technique error. A safe protocol depends on:
1. Doctor selection
At IVI, neurotoxin is only administered by MOH-licensed medical doctors with documented aesthetic training. We do not use nurses, technicians, or "treatment specialists" for injection.
2. Facial muscle assessment
Before injection, the doctor watches you make expressions: frown, raise eyebrows, smile, squint. They identify which muscles to target and which to leave alone. Imprecise injection can paralyse the wrong muscle and cause asymmetry or expression loss.
3. Conservative dosing
For first-time patients we typically dose at the lower end of the range. The dose can always be increased at a 2-week review; it cannot be reversed once injected. Conservative starting doses dramatically reduce the risk of over-treatment.
4. Anatomical injection points
Each injection follows established anatomical landmarks. Going off-protocol is how patients end up with classic complications — eyelid drooping (injecting too low on the forehead), asymmetric brows (injecting only one side incorrectly), or "frozen" expressions (over-treating the frontalis muscle).
5. The 2-week review
Effects develop over 7–14 days. At the 2-week mark, the doctor reviews how your face responded. Small touch-ups can adjust asymmetry or under-treated areas. Most reputable clinics include this review in the initial fee.
6. Honest contraindications
Not everyone is a candidate. Botulinum toxin is contraindicated in:
- Pregnancy or breastfeeding (precautionary; no clear evidence of harm but excluded from trials)
- Active neuromuscular disorders (myasthenia gravis, ALS, Lambert-Eaton syndrome)
- Known allergy to botulinum toxin or any product component
- Active infection at the planned injection site
- Concurrent use of certain medications (some antibiotics, muscle relaxants)
A proper consultation screens for these. Be honest in your medical history.
What "going wrong" actually looks like
The complications that get attention online cluster into a few patterns:
Eyelid drooping (ptosis)
Caused by toxin migrating to or being injected into the levator palpebrae muscle. Resolves in 4–8 weeks. Mitigation: experienced injector following anatomical landmarks; apraclonidine eye drops can give temporary functional improvement during resolution.
Brow heaviness or "spock brows"
Caused by uneven treatment of the frontalis muscle. Resolves naturally or can be corrected with a small additional dose at the appropriate point.
Frozen expression
Result of over-dosing. Wears off in 3–4 months. Mitigation: conservative dosing on first session, refine at 2-week review.
Headache
About 10% of patients experience a transient headache in the 24 hours after treatment. Usually mild, resolves with paracetamol. Repeat treatments typically have no headache.
Bruising at injection sites
Small bruises are normal and resolve within a week. To minimise: avoid blood-thinning medications (aspirin, ibuprofen, fish oil, alcohol) for 24 hours before treatment.
Red flags — warning signs of unsafe practice
- Unlicensed practitioners. If anyone other than a registered doctor offers to inject you, leave.
- Group buys, vouchers, deep discounts. Often signals counterfeit product or under-trained injector.
- No consultation before injection. Reputable doctors require a face-to-face consultation first.
- Pressure to commit on the spot. Reputable clinics give you time to decide.
- Product not shown. You should be able to see the vial label before injection — legitimate product, correct brand, intact seal.
- Treatments outside a clinic setting. "Botox parties" at salons, homes, or beauty bars are explicitly illegal in Singapore.
The bottom line
Botulinum toxin at therapeutic aesthetic doses, administered by an MOH-licensed doctor following standard protocol, is one of the safest procedures in modern medicine. The risks that exist are manageable, temporary, and rare. The risks that get amplified online — "BOTOX is poison" — conflate raw bacterial toxin with the highly diluted, dose-standardised pharmaceutical product.
That said, "safe in principle" still requires "safe in practice." Choose your injector carefully. Insist on a proper consultation. Start with conservative dosing. Use the 2-week review to fine-tune. Don't chase the cheapest deal — this is one area where price and safety correlate.
What to do next
If you're considering your first neurotoxin treatment, a consultation is the right next step. Our doctors will walk through your medical history, assess facial muscle dynamics, discuss conservative dosing, and answer any specific concerns. There's no pressure to proceed.